JP2011502994A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502994A5
JP2011502994A5 JP2010532265A JP2010532265A JP2011502994A5 JP 2011502994 A5 JP2011502994 A5 JP 2011502994A5 JP 2010532265 A JP2010532265 A JP 2010532265A JP 2010532265 A JP2010532265 A JP 2010532265A JP 2011502994 A5 JP2011502994 A5 JP 2011502994A5
Authority
JP
Japan
Prior art keywords
independently
group
halogen
optionally
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010532265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502994A (ja
JP5444239B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/081933 external-priority patent/WO2009073300A1/en
Publication of JP2011502994A publication Critical patent/JP2011502994A/ja
Publication of JP2011502994A5 publication Critical patent/JP2011502994A5/ja
Application granted granted Critical
Publication of JP5444239B2 publication Critical patent/JP5444239B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010532265A 2007-11-02 2008-10-31 タンパク質キナーゼＣ−θとしての［１Ｈ−ピラゾロ［３，４−Ｂ］ピリジン−４−イル］−フェニレンまたは−ピリジン−２−イル誘導体 Expired - Fee Related JP5444239B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US98487507P 2007-11-02 2007-11-02
US60/984,875 2007-11-02
US4457508P 2008-04-14 2008-04-14
US61/044,575 2008-04-14
US10080808P 2008-09-29 2008-09-29
US61/100,808 2008-09-29
PCT/US2008/081933 WO2009073300A1 (en) 2007-11-02 2008-10-31 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta

Publications (3)

Publication Number Publication Date
JP2011502994A JP2011502994A (ja) 2011-01-27
JP2011502994A5 true JP2011502994A5 (enExample) 2012-12-13
JP5444239B2 JP5444239B2 (ja) 2014-03-19

Family

ID=40220120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532265A Expired - Fee Related JP5444239B2 (ja) 2007-11-02 2008-10-31 タンパク質キナーゼＣ−θとしての［１Ｈ−ピラゾロ［３，４−Ｂ］ピリジン−４−イル］−フェニレンまたは−ピリジン−２−イル誘導体

Country Status (16)

Country Link
US (2) US8173635B2 (enExample)
EP (1) EP2215089B1 (enExample)
JP (1) JP5444239B2 (enExample)
KR (1) KR20100093552A (enExample)
CN (1) CN101903384A (enExample)
AR (1) AR069174A1 (enExample)
AU (1) AU2008331733A1 (enExample)
CA (1) CA2704266A1 (enExample)
CL (1) CL2008003280A1 (enExample)
ES (1) ES2389992T3 (enExample)
IL (1) IL205458A0 (enExample)
MX (1) MX2010004819A (enExample)
NZ (1) NZ585063A (enExample)
TW (1) TW200924762A (enExample)
WO (1) WO2009073300A1 (enExample)
ZA (1) ZA201003050B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3456189B2 (ja) 2000-03-31 2003-10-14 日本電気株式会社 移動通信システム
NZ592968A (en) 2006-01-17 2012-08-31 Vertex Pharma Azaindoles substituted with either triazine or pyrimidine useful as inhibitors of janus kinases consisting of JAK1, JAK2, JAK3, and TYK2
WO2008079346A1 (en) 2006-12-21 2008-07-03 Vertex Pharmaceuticals Incorporated 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
US8173635B2 (en) 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors
EP2262498A2 (en) * 2008-03-10 2010-12-22 Vertex Pharmceuticals Incorporated Pyrimidines and pyridines useful as inhibitors of protein kinases
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
MX2011001319A (es) 2008-08-06 2011-04-05 Vertex Pharma Inhibidores de aminopiridina cinasa.
RU2015144653A (ru) 2009-03-25 2018-12-29 Эббви Инк. Противовирусные соединения и их применения
WO2010129668A1 (en) * 2009-05-06 2010-11-11 Vertex Pharmaceuticals Incorporated Pyrazolopyridines
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
EP2528917B1 (en) * 2010-01-27 2016-10-19 Vertex Pharmaceuticals Incorporated Pyrazolopyridines useful for the treatment of autoimmune, inflammatory or (hyper)proliferative diseases
EP2582702A1 (en) 2010-01-27 2013-04-24 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
AU2011209649A1 (en) 2010-01-27 2012-08-09 Vertex Pharmaceuticals Incorporated Pyrazolopyrazine kinase inhibitors
MX2012008642A (es) * 2010-01-27 2012-11-23 Vertex Pharma Inhibidores de cinasas de pirazolopiridinas.
AU2010352577A1 (en) * 2010-05-05 2012-01-19 Vertex Pharmaceuticals Incorporated 4 substituted pyrazolopyrimidines useful as PKC-theta inhibitors
AU2011343647A1 (en) 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
JP2013545817A (ja) 2010-12-16 2013-12-26 バーテックス ファーマシューティカルズ インコーポレイテッド インフルエンザウイルス複製阻害物質
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2013184985A1 (en) 2012-06-08 2013-12-12 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3686181B1 (en) 2013-01-30 2024-07-17 Ecolab USA Inc. Hydrogen sulfide scavengers
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
PT3068776T (pt) 2013-11-13 2019-08-26 Vertex Pharma Inibidores da replicação de vírus da gripe
RU2016129380A (ru) 2013-12-20 2018-01-25 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
WO2016004305A2 (en) 2014-07-02 2016-01-07 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase
JP6640840B2 (ja) 2014-09-22 2020-02-05 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 線維症を処置するための方法及び医薬組成物
CN107438601B (zh) 2015-04-22 2020-11-13 艺康美国股份有限公司 开发用于去除硫化氢的高温稳定清除剂
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
WO2017044248A1 (en) 2015-09-08 2017-03-16 Ecolab Usa Inc. Hydrogen sulfide scavengers
WO2017044250A1 (en) 2015-09-08 2017-03-16 Ecolab Usa Inc. Hydrocarbon soluble/dispersible hemiformals as hydrogen sulfide scavengers
EP3491106B1 (en) 2016-07-29 2020-07-15 Ecolab Usa Inc. Antifouling and hydrogen sulfide scavenging compositions
EP4059934B1 (en) * 2016-09-09 2026-07-29 Novartis AG Compounds and compositions as inhibitors of endosomal toll-like receptors
US10538710B2 (en) 2017-07-13 2020-01-21 Ecolab Usa Inc. Hydrogen sulfide scavengers
US11499108B2 (en) 2019-01-23 2022-11-15 Championx Usa Inc. Complete removal of solids during hydrogen sulfide scavenging operations using a scavenger and a Michael acceptor
KR102922115B1 (ko) 2019-04-09 2026-02-04 누릭스 테라퓨틱스 인코포레이티드 Cbl-b 억제용의 3-치환된 피페리딘 화합물, 및 암 백신 및/또는 종양용해 바이러스와 조합된 cbl-b 억제제의 용도
CN111529533B (zh) * 2020-06-05 2021-06-11 南华大学附属第一医院 溴结构域蛋白4抑制剂jq1或其衍生物在制备治疗脓毒症肠屏障损伤药物中的应用
US20240262821A1 (en) * 2021-05-06 2024-08-08 Exscientia Al Limited PKC-Theta Modulators
CA3214088A1 (en) * 2021-05-06 2022-11-10 Peter Ray Pkc-theta modulators

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2080531A (en) 1936-01-08 1937-05-18 United Shoe Machinery Corp Manufacture of shoes
US3314941A (en) 1964-06-23 1967-04-18 American Cyanamid Co Novel substituted pyridodiazepins
GB1159487A (en) 1968-04-04 1969-07-23 Standard Telephones Cables Ltd Capacitors
US4988705A (en) 1985-06-13 1991-01-29 Schering Corporation Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
JP2890448B2 (ja) 1988-04-26 1999-05-17 日産化学工業株式会社 ピラゾロピリジン系メバロノラクトン類
US5100768A (en) 1989-05-09 1992-03-31 Kabushiki Kaisha Toshiba Photosensitive composition
JPH03206450A (ja) 1990-01-09 1991-09-09 Fuji Photo Film Co Ltd 新規な色素形成カプラー及びそれを用いたハロゲン化銀カラー写真感光材料及びその処理方法
JPH03271289A (ja) 1990-03-16 1991-12-03 Nissan Chem Ind Ltd ピラゾロピリジン誘導体の製造法及びジヒドロピラゾロピリジン誘導体
US5338740A (en) 1993-07-13 1994-08-16 Pfizer Inc. Angiotensin II receptor antagonists
US5646330A (en) 1995-02-17 1997-07-08 Ciba-Geigy Corporation Production of enantiomerically enriched ortho-substituted α,α-diaromatic methanols
US6194581B1 (en) 1995-04-07 2001-02-27 Merck & Co., Inc. Substituted pyridines useful as modulators of acetylcholine receptors
SE9704544D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
PE20010306A1 (es) 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
AR029289A1 (es) 2000-07-05 2003-06-18 Ishihara Sangyo Kaisha Derivado de benzoilpiridina o su sal, fungicida que lo contiene como un ingrediente activo, su proceso de produccion e intermediario para producirlo
JP2002020386A (ja) 2000-07-07 2002-01-23 Ono Pharmaceut Co Ltd ピラゾロピリジン誘導体
DE10035908A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
WO2002020500A2 (en) 2000-09-01 2002-03-14 Icos Corporation Materials and methods to potentiate cancer treatment
GB0128287D0 (en) 2001-11-26 2002-01-16 Smithkline Beecham Plc Novel method and compounds
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1463505A2 (en) * 2001-12-13 2004-10-06 Abbott Laboratories 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
DE10222550A1 (de) 2002-05-17 2003-11-27 Bayer Ag Substituierte Benzyl-pyrazolopyridine
DK1522314T3 (da) 2002-06-26 2014-05-26 Ono Pharmaceutical Co Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
US7186716B2 (en) 2002-08-12 2007-03-06 Sugen, Inc. 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
EP1590334B1 (en) * 2003-01-30 2009-08-19 Boehringer Ingelheim Pharmaceuticals Inc. 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
MXPA05009722A (es) 2003-03-10 2006-03-09 Schering Corp Inhibidores heterociclicos de cinasa: metodos de uso y sintesis.
US20050203067A1 (en) 2003-05-12 2005-09-15 Hresko Michelle C. Pesticidal compositions and methods
CA2533626A1 (en) 2003-07-22 2005-02-03 Janssen Pharmaceutica, N.V. Quinolinone derivatives as inhibitors of c-fms kinase
WO2005044181A2 (en) 2003-09-09 2005-05-19 Temple University-Of The Commonwealth System Of Higher Education Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
CN101061101B (zh) 2003-12-22 2011-09-07 巴斯利尔药物股份公司 芳酰基呋喃和芳酰基噻吩
UY29177A1 (es) 2004-10-25 2006-05-31 Astex Therapeutics Ltd Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
ATE554087T1 (de) 2004-10-29 2012-05-15 Abbott Lab Neue kinaseinhibitoren
WO2006050076A1 (en) 2004-10-29 2006-05-11 Janssen Pharmaceutica, N.V. Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
WO2006052568A2 (en) 2004-11-10 2006-05-18 Eli Lilly And Company Tgf-beta inhibitors
DE102004061288A1 (de) * 2004-12-14 2006-06-29 Schering Ag 3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
WO2006101456A1 (en) 2005-03-21 2006-09-28 S*Bio Pte Ltd Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors
AU2006247322A1 (en) * 2005-05-16 2006-11-23 Irm Llc Pyrrolopyridine derivatives as protein kinase inhibitors
AU2006272951A1 (en) 2005-05-17 2007-02-01 Plexxikon, Inc. Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
DE102005035417A1 (de) 2005-07-28 2007-02-01 Robert Bosch Gmbh Entfernungsmessgerät und Verfahren zum Befestigen einer elektrooptischen Einheit an einer Leiterträgereinheit
US7547782B2 (en) 2005-09-30 2009-06-16 Bristol-Myers Squibb Company Met kinase inhibitors
DE102005048897A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
WO2007076423A2 (en) 2005-12-22 2007-07-05 Smithkline Beecham Corporation INHIBITORS OF Akt ACTIVITY
WO2007084667A2 (en) 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Fused heterobicyclic kinase inhibitors
WO2007125321A2 (en) 2006-04-25 2007-11-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
TW200815438A (en) * 2006-06-13 2008-04-01 Bayer Schering Pharma Ag Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
ES2627352T3 (es) 2006-10-19 2017-07-27 Signal Pharmaceuticals, Llc Compuestos heteroarilo, sus composiciones y su uso como inhibidores de proteínas quinasas
JP2008132121A (ja) * 2006-11-28 2008-06-12 Sanshin Kinzoku Kogyo Kk 移動ラック装置
MX2009006543A (es) 2006-12-20 2009-06-26 Amgen Inc Compuestos heterociclicos y su uso en el tratamiento de la inflamacion, angiogenesis y cancer.
WO2008132121A1 (en) * 2007-04-26 2008-11-06 Glaxo Group Limited Lh-indazole-3-amine compounds as ikk1 inhibitors
US8173635B2 (en) 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors

Similar Documents

Publication Publication Date Title
JP6982376B2 (ja) Ｒｏｒガンマ調節物質としての置換型テトラヒドロキノリン化合物
JP2013530236A5 (enExample)
JP2021073298A (ja) ピリミジニルチロシンキナーゼ阻害剤
EP1781660A1 (en) Imidazopyrazine as tyrosine kinase inhibitors
JP2015502387A5 (enExample)
CA2813437A1 (en) Furo[3,2-d]pyrimidine compounds
JP7045528B2 (ja) Ｈｉｖに感染した細胞に対する選択的細胞毒性薬としてのピリミドン誘導体
JP4880097B1 (ja) Ｈｉｖインテグラーゼ阻害剤
JP2008533201A (ja) イミダゾピリダジン化合物
CN102924458A (zh) 6,6-双环取代的杂双环蛋白激酶抑制剂
Sun et al. Pyridine-phosphinimine ligand-accelerated Cu (i)-catalyzed azide–alkyne cycloaddition for preparation of 1-(pyridin-2-yl)-1, 2, 3-triazole derivatives
TW201605814A (zh) 用於合成經保護之ｎ－烷基三唑甲醛的三唑中間體
JP2016535732A5 (enExample)
JP2015525776A5 (enExample)
Goryaeva et al. The reactions of 2-ethoxymethylidene-3-oxo esters and their analogues with 5-aminotetrazole as a way to novel azaheterocycles
CN105189510A (zh) 人免疫缺陷病毒复制的抑制剂
JP2024519993A (ja) キノリンアミン系化合物、その調製方法及びその医薬的応用
Yu et al. Facile, eco-friendly, catalyst-free synthesis of polyfunctionalized 2-aminopyrroles
Wójtowicz-Rajchel et al. Synthesis of 5-fluorovinyl derivatives of pyrimidines via Suzuki–Miyaura coupling and their 1, 3-dipolar cycloaddition reactions with nitrones
EP3227298A1 (en) Process for the preparation of baricitinib and an intermediate thereof
KR102295416B1 (ko) 1-(피페라진-1-일)-2-([1,2,4]트리아졸-1-일)-에타논 유도체
Sugi et al. Environmentally friendly TPDS-mediated free radical ring expansion of α-haloalkyl cyclic β-keto esters
Beaudoin et al. Efficient, Scalable Syntheses of Important Intermediates in Tribenzotriquinacene Chemistry
Kaboudin et al. Iron (III) Chloride/L-proline as an efficient catalyst for the synthesis of 3-substituted 1, 2, 4-oxadiazoles from amidoximes and triethyl orthoformate
KR20210057008A (ko) 신규한 헤테로방향족 아미드 유도체 및 이를 함유하는 약제